Effect of Snakehead Fish Albumin Extract Supplementation on SGOT and SGPT Levels in Tuberculosis Patients
DOI:
10.29303/jbt.v26i2.11851Published:
2026-06-19Downloads
Abstract
Long-term use of OAT in tuberculosis patients carries a high risk of triggering drug-induced liver damage characterized by a spike in serum transaminase enzyme levels SGOT and SGPT. This study aims to determine the effect of snakehead fish extract therapy on SGOT and SGPT levels in TB patients undergoing intensive phase treatment. This study is quasi-experimental study with a randomized controlled trial design post-test only control group design. The research population was TB patients at the Sidotopo Community Health Center, Surabaya, who were selected using a random sampling technique purposive sampling until 20 respondents were obtained. Respondents were systematically divided into two groups, control group (OAT therapy) and treatment group (OAT therapy accompanied by supplementation of 500 mg albumin extract capsules). Comparative data analysis between groups was conducted using Independent Sample T-test. The results of the statistical analysis showed that the average SGOT level in intensive phase patients was 21.95 U/L and the average SGPT level was 19.65 U/L, where both valuesremained within normal clinical limits. The inter-group comparison hypothesis test produced a value p-value for SGOT levels of 0.907 and the value p-value for SGPT levels of 0.346. These data indicate no significant difference in the fluctuation of SGOT or SGPT levels between control and treatment groups. Supplementation with snakehead fish albumin extract did not show a significant difference in effect on SGOT and SGPT levels, but was proven to be able to maintain a stable and normal liver transaminase enzyme profile during intensive phase of OAT treatment.
Keywords:
Tuberculosis SGOT SGPT Snakehead Fish Albumin ExtractReferences
Allest, H. P., Nugraha, J., & Indrawati, R. (2024). Pengaruh ekstrak albumin ikan gabus (Channa striata) terhadap kadar IFN-gamma pasien tuberkulosis paru dengan pengobatan fase intensif. E-Jurnal Pustaka Kesehatan, 4(2), 1–7.
Aminah, S. (2021). Perbedaan kadar SGOT, SGPT, ureum, dan kreatinin pada penderita TB paru setelah enam bulan pengobatan. Jurnal Analis Kesehatan, 2(2), 260–269.
Andriyadi, R. (2025). Kerjasama Dinas Kesehatan TNI AU dengan Kementerian Kesehatan dalam program pengendalian tuberkulosis (TBC) di Jawa Barat untuk memperkuat pertahanan negara: Pendekatan strategis 2025-2026. Jurnal Impresi Indonesia, 4(7), 2659–2674.
Annisa, R., Zarfiardy, A. F., & Firdayenti. (2021). Perbandingan kadar SGPT pada pasien tuberkulosis paru sebelum dan sesudah intensif di poliklinik paru RSUD Arifin Achmad Pekanbaru. JOM FK, 2(2).
Ayu, N. D. R., & Adang. (2022). Perbedaan kadar SGOT-SGPT sebelum dan sesudah pemberian obat antituberkulosis fase awal (Karya Tulis Ilmiah/Skripsi tidak diterbitkan). Program Studi Pendidikan Dokter, Fakultas Kedokteran dan Ilmu Kesehatan Universitas Muhammadiyah Yogyakarta, Yogyakarta, Indonesia.
Hasanah, N., Ratnaningtyas, T. O., Razana, A., & Novian, D. R. (2020). Pengaruh obat anti tuberkulosis terhadap nilai SGPT dan SGOT berdasarkan usia dan jenis kelamin pasien tuberkulosis paru di RS Sari Asih Ciputat. Jurnal Ilmiah Farmasi, 9(2), 10–16.
Kementerian Kesehatan Republik Indonesia. (2025). Profil kesehatan Indonesia tahun 2024: Optimalisasi screening penemuan kasus tuberkulosis aktif. Kementerian Kesehatan RI.
Nova Dyah Ranti Ayu, & Adang. (2022). Perbedaan kadar SGOT-SGPT sebelum dan sesudah pemberian obat antituberkulosis fase awal (Karya Tulis Ilmiah, Universitas Muhammadiyah Yogyakarta).
Putri, T. M., & Widodo. (2021). Kadar SGOT, SGPT, dan bilirubin total pada pasien tuberkulosis paru. Jurnal Laboratorium Medis, 3(1), 15–22.
Sekarwati, M. D. (2025). Perbedaan kadar enzim SGOT dan SGPT pada pasien tuberkulosis paru yang sedang mengonsumsi obat anti tuberkulosis (OAT) dalam fase intensif dan fase lanjutan. Multidisciplinary Scientific Journal, 3(2), 338–348.
Sigalingging, I. N., Hidayat, W., & Tarigan, F. L. (2019). Pengaruh pengetahuan, sikap, riwayat kontak dan kondisi rumah terhadap kejadian TB paru di wilayah kerja UPTD Puskesmas Hutarakyat Kabupaten Dairi tahun 2019. Jurnal Ilmiah Simantek, 3(3).
Sri Eko, R. A. H. A. Y. U. (2021). Hubungan kadar SGOT-SGPT pada pasien TB pengobatan fase awal di Puskesmas Pati (Skripsi Doktoral, Universitas Muhammadiyah Semarang).
Ta, R. K., Khan, S., Sen, P., & Banerjee, S. (2020). A study to detect liver enzyme dysfunction among patients on first line antitubercular drugs from RNTCP during the course of anti-TB treatment. Journal of Evolution of Medical and Dental Sciences, 9(10), 645–650.
Ulfa, F., & Handayani, O. W. K. (2018). Higeia Journal of Public Health Research and Development. Higeia Journal of Public Health Research and Development, 2(2), 227–238
World Health Organization. (2024). Global tuberculosis report 2024. World Health Organization.
License
Copyright (c) 2026 Alfia Andriyani, Jusak Nugraha, Retno Indrawati, Theresia Budhy S, Nurul Hidayah, Mariana Asmaningdiah, Inas Hasna Azizah, Ahmad Hidayat
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
